• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 3.39% Nasdaq Down 4.12%

    Inovio Pharmaceuticals, Inc. (INO)

    -NasdaqGS
    9.17 Down 0.68(6.90%) Jun 24, 4:00PM EDT
    |After Hours : 9.33 Up 0.16 (1.74%) Jun 24, 7:58PM EDT
    Prev Close:9.85
    Open:9.11
    Bid:9.17 x 5000
    Ask:9.50 x 400
    1y Target Est:15.50
    Beta:2.89872
    Earnings Date:Aug 8 - Aug 12 (Est.)
    Day's Range:9.03 - 9.49
    52wk Range:4.50 - 11.69
    Volume:2,744,479
    Avg Vol (3m):1,792,230
    Market Cap:670.30M
    P/E (ttm):N/A
    EPS (ttm):-0.38
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    INODown 6.90%670.30M
    PFEDown 1.79%206.02B
    AZNDown 4.88%70.49B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):16.55
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.75
    Quarterly EPS Est (Jun-16) :-0.21
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback